GlassScriptPhysician profile
Julien Adicho
NPI 1134612872
$1,591.96
in general payments reported to CMS, 2019-2025
11 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $310 · 2022: $74.65 · 2023: $373 · 2024: $513 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,207.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $946.23 | 2021-2025 | Grafix Pl, Grafix, Stravix |
| Osteomed LLC | $189.19 | 2021 | |
| Tactile Systems Technology INC | $130.23 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Treace Medical Concepts, INC. | $96.26 | 2025 | |
| Abbvie INC. | $54.87 | 2021-2025 | |
| Melinta Therapeutics, LLC | $54.76 | 2021 | |
| Amgen INC. | $54.10 | 2025 | Krystexxa |
| Bioventus LLC | $31.56 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Bone Support INC. | $15.97 | 2024 | Cerament G, Ceramentbone Void Filler |
| Janssen Pharmaceuticals, INC | $15.16 | 2023 | Xarelto |
| Orthofix Medical, INC. | $3.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julien Adicho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.